CALLY Index Predicts Hypertension Risk in Diabetic Patients
New composite biomarker combining inflammation, nutrition, and immunity markers shows promise for cardiovascular risk assessment.
Summary
Researchers analyzed data from 4,163 diabetic adults and found that the CALLY index—a composite score combining C-reactive protein, albumin, and lymphocyte count—can predict hypertension risk. Higher CALLY scores were associated with 18% lower odds of having hypertension, suggesting this simple blood test could help identify diabetic patients at higher cardiovascular risk for earlier intervention.
Detailed Summary
Diabetes and hypertension frequently occur together, creating a dangerous combination that significantly increases cardiovascular disease risk. Identifying diabetic patients most likely to develop hypertension remains challenging, but new research suggests a simple composite blood marker could help.
Researchers analyzed data from 4,163 diabetic adults in the National Health and Nutrition Examination Survey (1999-2010) to examine the relationship between the CALLY index and hypertension prevalence. The CALLY index combines three readily available lab values: C-reactive protein (inflammation), albumin (nutrition), and lymphocyte count (immunity) into a single score.
The results were striking: participants with higher CALLY scores (upper quantile) had 18% lower odds of having hypertension compared to those with lower scores (OR = 0.82, 95% CI: 0.71-0.94, p = 0.004). Among all participants, 64% had hypertension. The relationship showed a nonlinear pattern, with protective effects becoming more pronounced at higher CALLY values.
This finding makes biological sense—the CALLY index captures three interconnected pathways involved in cardiovascular disease. Higher inflammation (elevated CRP) promotes blood vessel damage, while poor nutrition (low albumin) and weakened immunity (low lymphocyte count) compound these effects. Diabetic patients with better nutritional status, lower inflammation, and stronger immune function appear less likely to develop hypertension.
The clinical implications are significant. The CALLY index could serve as an inexpensive screening tool to identify high-risk diabetic patients who would benefit from more aggressive blood pressure monitoring and preventive interventions. However, this cross-sectional study cannot establish causation, and the findings need validation in prospective studies before clinical implementation.
Key Findings
- Higher CALLY index associated with 18% lower odds of hypertension in diabetic adults (OR = 0.82, p = 0.004)
- Study included 4,163 diabetic participants, with 64% having concurrent hypertension
- Nonlinear relationship observed, with protective effects increasing at higher CALLY values
- CALLY index integrates inflammation (CRP), nutrition (albumin), and immunity (lymphocyte count)
- Association remained significant after adjusting for age, sex, race, smoking, and socioeconomic factors
- Males comprised 52.3% of study population, with mean age of 61.7 ± 14.1 years
- Significant differences in CALLY scores observed across demographic groups (p < 0.001)
Methodology
Cross-sectional analysis of NHANES data (1999-2010) including 4,163 diabetic adults aged ≥18 years. CALLY index calculated as [albumin × lymphocyte count]/[CRP × 10⁴]. Multivariate logistic regression models adjusted for demographics, lifestyle factors, and blood parameters. Restricted cubic spline analysis used to assess nonlinear relationships.
Study Limitations
Cross-sectional design prevents establishing causation between CALLY index and hypertension. Study limited to US population and may not generalize to other ethnic groups. Cannot determine temporal relationship or whether improving CALLY scores reduces hypertension risk over time.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.